MARITIME-HF

Study Dates: Starts July 2026

We are evaluating a new medication for people living with heart failure and obesity. The study aims to determine whether this treatment can improve health outcomes and quality of life for people affected by these conditions. Throughout the study, we will assess how effective the drug is, while also monitoring its safety and how well it is tolerated. The findings will help us understand whether this new treatment could provide an additional option for people living with heart failure and obesity. Actively recruiting

Why Take Part

Taking part in research plays an important role in improving future healthcare. It may offer access to new treatments, contributes to the advancement of medical knowledge, and supports the work of your local NHS. Participation is always voluntary, and you are free to withdraw at any stage.

How to Join a Study

You may be invited to take part in a study through a text message, letter, email, or through posters and local advertisements. You can also visit our ‘Join a Study’ page to explore current opportunities.